Carmustine is a member of the antineoplastic nitrosourea compounds. Carmustine can perform both alkylating and carabamoylating action and owes part of its cytotoxicity to its demonstrated ability to produce interstrand DNA cross linking. In addition, this compound has been documented as an inhibitor of glutathione reductase, trypanothione reductase, and lipoamide dehydrogenase (DLD).
1. Schabel, F.M. 1976. Cancer Treat Rep. 60: 665-698. PMID: 782694
2. Puglia, C.D., et al. 1984. Environ. Health Perspect. 57: 307-311. PMID: 6094175
3. Lohrer, H. and Krauth-Siegel, R.L. 1990. Eur. J. Biochem. 194: 863-869. PMID: 2269305
4. Arscott, L.D., et al. 1997. Proc. Natl. Acad. Sci. U.S.A. 94: 3621-3626. PMID: 9108027
5. Pratt, B.W., et al. 1994. The Anticancer Drugs. Oxoford Universtiy Press Inc. N.Y., N.Y.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.